Your browser doesn't support javascript.
loading
Phase II study of everolimus and bevacizumab in recurrent ovarian, peritoneal, and fallopian tube cancer.
Taylor, Sarah E; Chu, Tianjiao; Elvin, Julia A; Edwards, Robert P; Zorn, Kristin K.
Afiliação
  • Taylor SE; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences University of Pittsburgh, Pittsburgh, PA, USA; Magee-Womens Research Institute, Pittsburgh, PA, USA. Electronic address: taylorse2@upmc.edu.
  • Chu T; Magee-Womens Research Institute, Pittsburgh, PA, USA.
  • Elvin JA; Foundation Medicine, Cambridge, MA, USA.
  • Edwards RP; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences University of Pittsburgh, Pittsburgh, PA, USA; Magee-Womens Research Institute, Pittsburgh, PA, USA.
  • Zorn KK; University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Gynecol Oncol ; 156(1): 32-37, 2020 01.
Article em En | MEDLINE | ID: mdl-31739991
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Peritoneais / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias das Tubas Uterinas / Carcinoma Epitelial do Ovário Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Peritoneais / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias das Tubas Uterinas / Carcinoma Epitelial do Ovário Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article